Pharmaceutical pricing, cost containment and new treatments for rare diseases in children

por Stella, Peter, Gold-von Simson, Gabrielle
Publicado 2014

Insulin Glargine 300 U/mL and Insulin Glulisine Treatment in Patients with Type 2 Diabetes: A Non-Interventional Study of Effectiveness in Routine Clinical Practice

por Hidvégi, Tibor, Balogh, Zoltán, Vass, Viktor, Kovács, Gábor, Stella, Péter
Publicado 2020

Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study

por Mathieu, Chantal, Weisnagel, S. John, Stella, Peter, Bruhwyler, Jacques, Alexandre, Kathy
Publicado 2020

Association of Patient Profile with Glycemic Control and Hypoglycemia with Insulin Glargine 300 U/mL in Type 2 Diabetes: A Post Hoc Patient-Level Meta-Analysis

por Twigg, Stephen M., Escalada, Javier, Stella, Peter, Merino-Trigo, Ana, Lavalle-Gonzalez, Fernando J., Cariou, Bertrand, Meneghini, Luigi F.
Publicado 2018

Validation of parsimonious prognostic models for patients infected with COVID-19

por Harish, Keerthi, Zhang, Ben, Stella, Peter, Hauck, Kevin, Moussa, Marwa M, Adler, Nicole M, Horwitz, Leora I, Aphinyanaphongs, Yindalon
Publicado 2021

Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA

por Mauricio, Dídac, Meneghini, Luigi, Seufert, Jochen, Liao, Laura, Wang, Hongwei, Tong, Liyue, Cali, Anna, Stella, Peter, Carita, Paulo, Khunti, Kamlesh
Publicado 2017

Treatment Dosing Patterns and Clinical Outcomes for Patients with Type 2 Diabetes Starting or Switching to Treatment with Insulin Glargine (300 Units per Milliliter) in a Real-Worl...

por Gupta, Shaloo, Wang, Hongwei, Skolnik, Neil, Tong, Liyue, Liebert, Ryan M., Lee, Lulu K., Stella, Peter, Cali, Anna, Preblick, Ronald
Publicado 2018

Safety, tolerability and effects on cardiometabolic risk factors of empagliflozin monotherapy in drug-naïve patients with type 2 diabetes: a double-blind extension of a Phase III r...

por Roden, Michael, Merker, Ludwig, Christiansen, Anita Vedel, Roux, Flavien, Salsali, Afshin, Kim, Gabriel, Stella, Peter, Woerle, Hans J., Broedl, Uli C.
Publicado 2015

The effect of concomitant DPPIVi use on glycaemic control and hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus insulin glargine 100 U/mL (Gla-100) in people with type...

por Yale, Jean-François, Pettus, Jeremy Hodson, Brito-Sanfiel, Miguel, Lavalle-Gonzalez, Fernando, Merino-Trigo, Ana, Stella, Peter, Chevalier, Soazig, Buzzetti, Raffaella
Publicado 2018

Efficacy and Safety of iGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared with Basal-Bolus Regimen in Patients with Type 2 Diabetes: Propensity Score...

por Tabák, Ádám G., Anderson, John, Aschner, Pablo, Liu, Minzhi, Saremi, Aramesh, Stella, Peter, Tinahones, Francisco J., Wysham, Carol, Meier, Juris J.
Publicado 2019

Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice‐daily basal insulin to once‐daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (ED...

por Roussel, Ronan, d'Emden, Michael C., Fisher, Miles, Ampudia‐Blasco, F. Javier, Stella, Peter, Bizet, Florence, Cali, Anna M. G., Wysham, Carol H.
Publicado 2017

The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real‐world setting

por Meneghini, Luigi F., Mauricio, Didac, Orsi, Emanuela, Lalic, Nebojsa M., Cali, Anna M.G., Westerbacka, Jukka, Stella, Peter, Candelas, DEA, Christophe, Pilorget, Valerie, Perfetti, Riccardo, Khunti, Kamlesh
Publicado 2019

A validated, real-time prediction model for favorable outcomes in hospitalized COVID-19 patients

por Razavian, Narges, Major, Vincent J., Sudarshan, Mukund, Burk-Rafel, Jesse, Stella, Peter, Randhawa, Hardev, Bilaloglu, Seda, Chen, Ji, Nguy, Vuthy, Wang, Walter, Zhang, Hao, Reinstein, Ilan, Kudlowitz, David, Zenger, Cameron, Cao, Meng, Zhang, Ruina, Dogra, Siddhant, Harish, Keerthi B., Bosworth, Brian, Francois, Fritz, Horwitz, Leora I., Ranganath, Rajesh, Austrian, Jonathan, Aphinyanaphongs, Yindalon
Publicado 2020